IGI Laboratories to Hold Conference Call for 2nd Quarter 2013 Results

Before you go, we thought you'd like these...
Before you go close icon

IGI Laboratories to Hold Conference Call for 2nd Quarter 2013 Results

BUENA, N.J.--(BUSINESS WIRE)-- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced the Company will hold a conference call at 4:30 pm ET on Thursday, July 25, 2013 to discuss 2nd quarter 2013 results.

The Company invites you to listen to the call by dialing 1-866-515-2909. International participants should call 1-617-399-5123. The passcode for the conference call is 19569314.


This call is being webcast by Thomson and can be accessed at IGI's website at www.igilabs.com.

The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents (www.streetevents.com), a password-protected event management site.

About IGI Laboratories, Inc.

IGI Laboratories is a developer and manufacturer of topical formulations for the pharmaceutical, OTC, and cosmetic markets. Our mission is to be a leading player in the generic topical prescription drug market.



IGI Laboratories, Inc.
Jenniffer Collins, 856-697-1441
www.igilabs.com

KEYWORDS:   United States  North America  New Jersey

INDUSTRY KEYWORDS:

The article IGI Laboratories to Hold Conference Call for 2nd Quarter 2013 Results originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners